Search Results 11-20 of 12551 for immunothérapie
The Department of Cancer Biology at Mayo Clinic is developing strategies to stimulate the immune system to target cancer cells for tumor regression and ...
New blood test maps tumor environments to better predict immunotherapy response and personalize cancer treatment.
Mayo Clinic's Aging & Immune Restoration Lab led by Jessica N. Lancaster, Ph.D., visualizes T & B cells to learn how the immune system breaks down with age, ...
If your healthcare professional recommends a monoclonal antibody medicine as part of your cancer treatment, find out what to expect from this therapy. Learn ...
Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...
The objectives of this study are to create a proteomic profile (Host Response) using plasma from patients before and after anti-cancer therapy, and to associate ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
This study will test a study drug called cemiplimab to see if it can help treat early-stage Cutaneous Squamous Cell Carcinoma (CSCC), a type of skin cancer.
The purpose of this study is to sequence patient germline and tumor samples, and nominate top neoantigen candidates using an in-house developed bioinformatics ...
“Immune checkpoint therapy with PD-1 blockade has emerged as an effective treatment for many advanced cancers,” says the study's lead author, Roxana Dronca, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.